Loading insider details...
Latest Form 4 (Nov 6, 2026): Purchase of 5,586 MDGL shares, $2.05M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Purchase | 5,586 | $2.05M |
| Nov 6, 2026 | Kodiak Sciences Inc. (KOD) | Purchase | 8,742 | $861.2K |
| Oct 2, 2026 | INCYTE CORP (INCY) | Grant/Award | 322 | n/a |
| Sep 30, 2026 | Kodiak Sciences Inc. (KOD) | Purchase | 186 | $16.1K |
| Sep 30, 2026 | Kodiak Sciences Inc. (KOD) | Purchase | 534 | $42.4K |
| Sep 30, 2026 | Kodiak Sciences Inc. (KOD) | Purchase | 856 | $52.4K |
| Aug 11, 2026 | Replimune Group, Inc. (REPL) | Purchase | 126,394 | $1.52M |
| Jul 16, 2026 | Celcuity Inc. (CELC) | Sale | 261,368 | $26.79M |
| Jul 2, 2026 | Kodiak Sciences Inc. (KOD) | Grant/Award | 17,731 | n/a |
| Jul 2, 2026 | INCYTE CORP (INCY) | Grant/Award | 400 | n/a |